Biotechnology in the United States
Summary
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the United States biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The US biotechnology industry had total revenues of $164.6bn in 2016, representing a compound annual growth rate (CAGR) of 12.9% between 2012 and 2016.
- The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $96.9bn, equivalent to 58.9% of the industry's overall value.
- One area of concern in the US biotechnology industry is the fact that consumers are increasingly becoming wary of food products containing GMOs.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts
Reasons to buy
- What was the size of the United States biotechnology market by value in 2016?
- What will be the size of the United States biotechnology market in 2021?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the United States's biotechnology market?
Table of Contents
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Baxter International Inc.
Biogen, Inc.
Merck & Co., Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: United States biotechnology industry value: $ billion, 2012-16
Table 2: United States biotechnology industry category segmentation: $ billion, 2016
Table 3: United States biotechnology industry geography segmentation: $ billion, 2016
Table 4: United States biotechnology industry value forecast: $ billion, 2016-21
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Baxter International Inc.: key facts
Table 9: Baxter International Inc.: key financials ($)
Table 10: Baxter International Inc.: key financial ratios
Table 11: Biogen, Inc.: key facts
Table 12: Biogen, Inc.: key financials ($)
Table 13: Biogen, Inc.: key financial ratios
Table 14: Merck & Co., Inc.: key facts
Table 15: Merck & Co., Inc.: key financials ($)
Table 16: Merck & Co., Inc.: key financial ratios
Table 17: United States size of population (million), 2012-16
Table 18: United States gdp (constant 2005 prices, $ billion), 2012-16
Table 19: United States gdp (current prices, $ billion), 2012-16
Table 20: United States inflation, 2012-16
Table 21: United States consumer price index (absolute), 2012-16
Table 22: United States exchange rate, 2012-15
List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2012-16
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2016
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2016
Figure 4: United States biotechnology industry value forecast: $ billion, 2016-21
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2016
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2016
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2016
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2016
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2016
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2016
Figure 11: Amgen, Inc.: revenues & profitability
Figure 12: Amgen, Inc.: assets & liabilities
Figure 13: Baxter International Inc.: revenues & profitability
Figure 14: Baxter International Inc.: assets & liabilities
Figure 15: Biogen, Inc.: revenues & profitability
Figure 16: Biogen, Inc.: assets & liabilities
Figure 17: Merck & Co., Inc.: revenues & profitability
Figure 18: Merck & Co., Inc.: assets & liabilities
